Malaria

Malaria is a life-threatening infectious disease caused by Plasmodium parasites, which are transmitted to humans through the bites of infected female Anopheles mosquitoes. It primarily affects tropical and subtropical regions

Signs and Symptoms

  • Fever

  • Chills

  • Sweating

  • Headache

  • Muscle and joint pain

  • Fatigue

  • Nausea and vomiting

  • Diarrhea (in some cases)

  • Abdominal pain

  • Anemia (due to destruction of red blood cells)

  • Jaundice (yellowing of the skin and eyes)

  • Rapid breathing and heart rate

Complications

  • Severe anemia

  • Cerebral malaria (brain infection leading to seizures and coma)

  • Acute respiratory distress syndrome (ARDS)

  • Kidney failure

  • Liver failure

  • Shock and multi-organ failure

  • Hypoglycemia (low blood sugar)

  • Stillbirth or low birth weight in pregnant women

Transmission

  • Bite of an infected female Anopheles mosquito

  • Blood transfusion from an infected person

  • Sharing of contaminated needles or syringes

  • Congenital transmission (from mother to fetus during pregnancy or childbirth)

Causative Agent

Malaria is caused by Plasmodium parasites. The five main species that infect humans are:

  1. Plasmodium falciparum (most severe and deadly)

  2. Plasmodium vivax

  3. Plasmodium ovale

  4. Plasmodium malariae

  5. Plasmodium knowlesi (zoonotic malaria)

Incubation Period

  • P. falciparum: 9–14 days

  • P. vivax & P. ovale: 12–18 days

  • P. malariae: 18–40 days

  • P. knowlesi: ~11–12 days

Reservoir

  • Humans (primary reservoir)

  • Some species (P. knowlesi) can also be found in monkeys

Prevention and Control

  • Vector Control:

  • Use insecticide-treated mosquito nets (ITNs)

  • Indoor residual spraying (IRS) with insecticides

  • Eliminate mosquito breeding sites (stagnant water)

  • Personal Protection:

  • Wear long-sleeved clothing and use insect repellents

  • Stay indoors during peak mosquito activity (dusk to dawn)

  • Chemoprevention:

  • Intermittent preventive treatment (IPT) in pregnant women and infants

  • Prophylactic antimalarial drugs for travelers to endemic areas

  • Vaccination:

  • RTS,S/AS01 (Mosquirix) vaccine is available for children in high-risk areas

Treatment

  • Uncomplicated Malaria:

    • Artemisinin-based combination therapies (ACTs) (e.g., Artemether-Lumefantrine)

    • Chloroquine (only for P. vivax and P. malariae where resistance is absent)

  • Severe Malaria:

    • Intravenous (IV) Artesunate followed by ACTs

    • Supportive care (fluids, blood transfusion, oxygen therapy)

  • Relapse Prevention:

    • Primaquine for P. vivax and P. ovale to eliminate dormant liver stages (hypnozoites)


Comments

Post a Comment

Popular posts from this blog

Yellow Fever

Measles

Tuberculosis

Covid-19 (Coronavirus)

Diphtheria

Human Papillomavirus (HPV)

Acute Flaccid Paralysis (AFP)

Injection Safety